Blood Products Voluntarily Withdrawn to Reduce West Nile Virus Risk
December 12, 2002
The Food and Drug Administration (FDA) has been working with the Centers for Disease Control and Prevention (CDC) and the blood banking community to assess and manage the potential risk of West Nile Virus transmission from blood and blood products. A small number of cases of West Nile Virus infection have been linked to the receipt of blood products that carried the virus. The estimated risk to recipients of blood and blood products is thought to be low; but it varies by region and time period of the epidemic.
In October 2002, FDA issued a final guidance document that provided recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile Virus infection.
Although the risk from an individual unit of blood or plasma collected and frozen during the epidemic is likely to be low, FDA believes that the voluntary withdrawal of certain frozen products is a rational response to the risk at this time.
-- Article Courtesy of InjuryBoard.com
More ...
- Florida Boy May Have Contracted West Nile From Blood Donation
- West Nile Virus Discovered in Three Blood Donations
- Two Tampa Bay Residents Contract HIV From Blood Transfusion
.